← Back to Search

Speech Therapy for Down Syndrome

N/A
Recruiting
Led By Stephen Camarata, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Previous medical identification of Down Syndrome
Chronological age 6-14 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights

Study Summary

This trial is measuring speech-articulation accuracy and speech intelligibility in children with Down Syndrome to see if a treatment can help improve speech intelligibility.

Who is the study for?
This trial is for children with Down Syndrome aged 6 to 14 who can use at least three-word sentences, as reported by parents. They must pass a hearing test and have no history of seizures, ADHD, apraxia due to neurological disorders, stuttering, autism (as measured by specific diagnostic scales), or severe disruptive behavior.Check my eligibility
What is being tested?
The study tests the effectiveness of a speech therapy called 'Lexically based speech recast' in improving the clarity of speech in children with Down Syndrome. It will assess how well they articulate words and understand vocabulary before and after treatment.See study design
What are the potential side effects?
Since this intervention involves speech therapy techniques without medication or surgery, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Down Syndrome.
Select...
I am between 6 and 14 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Speech Accuracy
Speech Intelligibility
Secondary outcome measures
Speech Rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lexically Based Speech Intelligibility RecastExperimental Treatment1 Intervention
Speech recasts are likely to improve speech intelligibility in Down Syndrome. The goal of this study is to induce change in speech intelligibility in order to study phonological, acoustic and suprasegmental sequelae of improvements in speech.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
672,137 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
328 Previous Clinical Trials
178,276 Total Patients Enrolled
Stephen Camarata, PhDPrincipal InvestigatorVUMC Dept of Hearing & Speech Sciences
1 Previous Clinical Trials
72 Total Patients Enrolled

Media Library

Lexically based speech recast Clinical Trial Eligibility Overview. Trial Name: NCT05016037 — N/A
Speech Intelligibility Intervention Research Study Groups: Lexically Based Speech Intelligibility Recast
Speech Intelligibility Intervention Clinical Trial 2023: Lexically based speech recast Highlights & Side Effects. Trial Name: NCT05016037 — N/A
Lexically based speech recast 2023 Treatment Timeline for Medical Study. Trial Name: NCT05016037 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial have an age restriction, and if so, what is it?

"Candidates that meet the particular criteria of this medical trial must be between 6 and 14 years old."

Answered by AI

How many participants have enrolled in this clinical trial thus far?

"Affirmative. According to clinicaltrials.gov, this medical trial is currently enlisting volunteers and was first made available on February 14th 2022. The last update occurred on May 2nd 202022 with the aim of recruiting 20 patients from one treatment centre."

Answered by AI

Am I qualified to partake in this clinical research?

"This clinical trial has 20 openings for individuals with Down syndrome between the ages of 6 and 14. Essential criteria applicants must meet include using 3-word utterances, having a confirmed medical diagnosis of Down Syndrome, and passing an audiological screening (25 dB @1000, 2000, 4000 Hz)."

Answered by AI

Are there any available slots left for participants to join this trial?

"Affirmative. The data on clinicaltrials.gov reflects that the timeline of this trial began February 14th, 2022 and was recently updated May 2nd of the same year. 20 individuals are sought from a singular site for participation in this research study."

Answered by AI
~6 spots leftby Apr 2025